[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Times XXX Malawi [@Times360Malawi](/creator/twitter/Times360Malawi) on x 161.8K followers Created: 2025-06-21 20:07:37 UTC #Times360Malawi The U.S. Food and Drug Administration has approved Gilead Sciences, lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo.  XXXXXX engagements  **Related Topics** [approved](/topic/approved) [malawi](/topic/malawi) [Post Link](https://x.com/Times360Malawi/status/1936516377101164561)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Times XXX Malawi @Times360Malawi on x 161.8K followers
Created: 2025-06-21 20:07:37 UTC
#Times360Malawi The U.S. Food and Drug Administration has approved Gilead Sciences, lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo.
XXXXXX engagements
/post/tweet::1936516377101164561